Hematopoiesis post anti-CD117 monoclonal antibody treatment in wild-type and Fanconi anemia settings

Anti-CD117 monoclonal antibody (mAb) agents have emerged as exciting alternative conditioning strategies to traditional genotoxic irradiation or chemotherapy conditioning for both allogeneic and autologous gene-modified hematopoietic stem cell transplantation. Further, these agents are concurrently...

Full description

Bibliographic Details
Published in:Haematologica
Main Authors: Morgane Denis, Leah Swartzrock, Hana Willner, Quenton R. Bubb, Ethan Haslett, Yan Yi Chan, Anzhi Chen, Mark R. Krampf, Agnieszka D. Czechowicz
Format: Article
Language:English
Published: Ferrata Storti Foundation 2024-04-01
Online Access:https://haematologica.org/article/view/11536